🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is researching an experimental drug called ALN-APOC3 (called "st...
Status
Completed
Location
Arensia Exploratory Medicine at the Republican Clinical Hospital
Start Date
2025-01-27
Trial ID
NCT06784349
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
A study to evaluate the PK and PD of oral IN-105 (Insulin Tregopil) w.r.t. ...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-27
Trial ID
NCT03392961
Treatments Being Tested
This randomized, multicenter, double-blind, placebo-controlled, parallel-gr...
Status
Completed
Location
University Alabama At Birmingham
Start Date
2013-10-13
Trial ID
NCT01872689
Treatments Being Tested
Food allergy is a serious public health concern that causes potentially-lif...
Status
Completed
Location
University of California Los Angeles (UCLA)
Start Date
2020-02-05
Trial ID
NCT03679676
Treatments Being Tested
This first-in-human clinical trial with a randomized, double-blind, placebo...
Status
Completed
Location
Parexel Los Angeles Early Phase Clinical Unit
Start Date
2023-12-21
Trial ID
NCT06225115
This study is being done for the following reasons: To determine the safet...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-03
Trial ID
NCT01807026
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Completed
Location
Anapharm
Start Date
2008-07
Trial ID
NCT00734240